Matches in Wikidata for { <http://www.wikidata.org/entity/Q100433646> ?p ?o ?g. }
Showing items 1 to 61 of
61
with 100 items per page.
- Q100433646 description "article scientifique publié en 2020" @default.
- Q100433646 description "artículu científicu espublizáu n'ochobre de 2020" @default.
- Q100433646 description "scientific article published on 02 October 2020" @default.
- Q100433646 description "wetenschappelijk artikel" @default.
- Q100433646 description "наукова стаття, опублікована 2 жовтня 2020" @default.
- Q100433646 name "Safety and Efficacy of Locoregional Treatment during Immunotherapy with Nivolumab for Hepatocellular Carcinoma: A Retrospective Study of 41 Interventions in 29 Patients" @default.
- Q100433646 name "Safety and Efficacy of Locoregional Treatment during Immunotherapy with Nivolumab for Hepatocellular Carcinoma: A Retrospective Study of 41 Interventions in 29 Patients" @default.
- Q100433646 name "Safety and Efficacy of Locoregional Treatment during Immunotherapy with Nivolumab for Hepatocellular Carcinoma: A Retrospective Study of 41 Interventions in 29 Patients" @default.
- Q100433646 type Item @default.
- Q100433646 label "Safety and Efficacy of Locoregional Treatment during Immunotherapy with Nivolumab for Hepatocellular Carcinoma: A Retrospective Study of 41 Interventions in 29 Patients" @default.
- Q100433646 label "Safety and Efficacy of Locoregional Treatment during Immunotherapy with Nivolumab for Hepatocellular Carcinoma: A Retrospective Study of 41 Interventions in 29 Patients" @default.
- Q100433646 label "Safety and Efficacy of Locoregional Treatment during Immunotherapy with Nivolumab for Hepatocellular Carcinoma: A Retrospective Study of 41 Interventions in 29 Patients" @default.
- Q100433646 prefLabel "Safety and Efficacy of Locoregional Treatment during Immunotherapy with Nivolumab for Hepatocellular Carcinoma: A Retrospective Study of 41 Interventions in 29 Patients" @default.
- Q100433646 prefLabel "Safety and Efficacy of Locoregional Treatment during Immunotherapy with Nivolumab for Hepatocellular Carcinoma: A Retrospective Study of 41 Interventions in 29 Patients" @default.
- Q100433646 prefLabel "Safety and Efficacy of Locoregional Treatment during Immunotherapy with Nivolumab for Hepatocellular Carcinoma: A Retrospective Study of 41 Interventions in 29 Patients" @default.
- Q100433646 P1433 Q100433646-5DC23ADF-9EE1-4CE7-A71F-6F2CC552A28F @default.
- Q100433646 P1476 Q100433646-4AFA27B5-4410-4747-A9B4-CCEAF9270F90 @default.
- Q100433646 P2093 Q100433646-286C3F3C-A70E-475B-962E-473999EA5312 @default.
- Q100433646 P2093 Q100433646-2C2C7016-FBAF-4955-99AF-93CD1086FC05 @default.
- Q100433646 P2093 Q100433646-3CC596A1-405B-4800-9806-C7F062A18C75 @default.
- Q100433646 P2093 Q100433646-56DD15C3-629A-436F-A824-1947C7998B64 @default.
- Q100433646 P2093 Q100433646-67F93610-A7A3-475D-A084-ED91DDA89279 @default.
- Q100433646 P2093 Q100433646-69F576FE-2069-4937-8EC2-164A4E7B45FA @default.
- Q100433646 P2093 Q100433646-6AB37067-FBDC-4219-8E4B-C87A79FEA1D1 @default.
- Q100433646 P2093 Q100433646-829534E5-CFF0-44B0-BEFA-5415497110AC @default.
- Q100433646 P2093 Q100433646-982E6A21-E180-4433-BF7F-0F1FDA41E149 @default.
- Q100433646 P2093 Q100433646-98B9217D-D92A-4572-AF89-781986A6DD3B @default.
- Q100433646 P2093 Q100433646-A608C49F-910D-4088-8341-7FE5C1237CC3 @default.
- Q100433646 P2093 Q100433646-B7A3DB99-16D0-4E85-AB7E-AC6D1ECA0C32 @default.
- Q100433646 P2093 Q100433646-C3E4195E-39EE-4477-8F95-7BBC885278B5 @default.
- Q100433646 P2093 Q100433646-D22BE443-D169-4DDE-A84A-511B526D621D @default.
- Q100433646 P2093 Q100433646-E48D479B-B98D-477A-B9B3-0A18581F95C9 @default.
- Q100433646 P31 Q100433646-3418428C-0272-4F99-A7F3-746C38E5142A @default.
- Q100433646 P356 Q100433646-377B6300-6592-4F27-B7FC-FA234C6D35A0 @default.
- Q100433646 P577 Q100433646-B1220941-EB7A-43AD-AE8E-AF538091C088 @default.
- Q100433646 P698 Q100433646-800DF741-3098-488A-BCE2-E6C9870C08D1 @default.
- Q100433646 P921 Q100433646-CCA50CA7-B737-4FFA-963D-F74417EBD36D @default.
- Q100433646 P356 J.JVIR.2020.07.009 @default.
- Q100433646 P698 33012649 @default.
- Q100433646 P1433 Q15766548 @default.
- Q100433646 P1476 "Safety and Efficacy of Locoregional Treatment during Immunotherapy with Nivolumab for Hepatocellular Carcinoma: A Retrospective Study of 41 Interventions in 29 Patients" @default.
- Q100433646 P2093 "Aaron Fischman" @default.
- Q100433646 P2093 "Brett Marinelli" @default.
- Q100433646 P2093 "Dudley Charles" @default.
- Q100433646 P2093 "Edward Kim" @default.
- Q100433646 P2093 "Mario Cedillo" @default.
- Q100433646 P2093 "Max Sung" @default.
- Q100433646 P2093 "Monda Ranade" @default.
- Q100433646 P2093 "Myron Schwartz" @default.
- Q100433646 P2093 "Rahul S Patel" @default.
- Q100433646 P2093 "Robert Lookstein" @default.
- Q100433646 P2093 "Sara D Pasik" @default.
- Q100433646 P2093 "Scott Nowakowski" @default.
- Q100433646 P2093 "Shashi Murthy" @default.
- Q100433646 P2093 "Thomas Marron" @default.
- Q100433646 P2093 "Vivian Bishay" @default.
- Q100433646 P31 Q13442814 @default.
- Q100433646 P356 "10.1016/J.JVIR.2020.07.009" @default.
- Q100433646 P577 "2020-10-02T00:00:00Z" @default.
- Q100433646 P698 "33012649" @default.
- Q100433646 P921 Q1427096 @default.